Welcome to This Is MS!

     Modules
· Home
· Content
· Downloads
· Encyclopedia
· FAQ
· Feedback
· Forums
· Journal
· Private Messages
· Recommend Us
· Search
· Site_Map
· Stories Archive
· Submit News
· Surveys
· Top 10
· Topics
· Web Links
· Your Account

     Google
Google
Web
This is MS
These ads help pay for the upkeep of our site. They are automatically served by Google and are not affiliated with This is MS.

     Languages
Select Interface Language:


     Who's Online
There are currently, 147 guest(s) and 8 member(s) that are online.

You are Anonymous user. You can register for free by clicking here

     Next Step

From the creators of This is MS comes Experience Project

EP is a community where members connect through shared life experiences-- like MS--and so much more. You are not defined by any one thing, so be your true self and find others just like you at Experience Project.

Get started by sharing your Multiple Sclerosis story.


     Donations

To remain unbiased, This is MS does not accept corporate sponsorships.

Therefore, we must rely on our users to help support us. Please donate to our upkeep if you have the means. Thank you!
ThisIsMS.com :: View topic - Transition Therapeutics
 Forum FAQForum FAQ   SearchSearch   UsergroupsUsergroups   ProfileProfile   Log in to check your private messagesLog in to check your private messages   Log inLog in 


Transition Therapeutics

 
Post new topic   Reply to topic    ThisIsMS.com Forum Index -> Drug Pipeline
View previous topic :: View next topic  
Author Message
bromley
Family Elder


Joined: Sep 11, 2004
Posts: 1819
PostPosted: Fri Apr 21, 2006 3:03 pm    Post subject: Transition Therapeutics Reply with quote
Dignan,

I stumbled across Transition Therapeutics (Canadian company). They have the following drug/s? in trial. Not sure if it / they are on your list?

Ian

Clinical Development

A Phase II clinical trial is underway in MS patients with data expected in the second half of calendar 2006. A Phase I clinical trial has demonstrated that EMZ701 is well-tolerated and has a good safety profile.

Creating Best-In-Class Multiple Sclerosis Product

Transition is developing MS-I.E.T. (a combination of Transition's interferon enhancer EMZ701 and interferon-beta) which has been shown to improve interferon therapy two to three-fold in MS animal models.
Back to top
View user's profile Send private message
dignan
Family Elder


Joined: Aug 12, 2004
Posts: 1147
PostPosted: Fri Apr 21, 2006 3:20 pm    Post subject: Reply with quote
Got it -- under phase II "interferon enhancing therapy"...thanks for digging though.
Back to top
View user's profile Send private message
Display posts from previous:   
Post new topic   Reply to topic    ThisIsMS.com Forum Index -> Drug Pipeline All times are GMT - 6 Hours
Page 1 of 1

 
Jump to:  
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot vote in polls in this forum





Personal Stories about millions of life experience--including multiple sclerosis support, lupus support, depression support . Built by the This is MS team.

Anonymous Confessions | Dream Dictionary
Site Map

This site does not offer medical advice. All treatment decisions should always be made with the full consent of your physician.


Visit our sister site dedicated to Inflammatory Bowel Disease: This is IBD


All logos and trademarks in this site are property of their respective owners. The comments are property of their posters, quoted articles are © referenced source, all the rest © 2002 by thisisMS.com.
PHP-Nuke Copyright © 2005 by Francisco Burzi. This is free software, and you may redistribute it under the GPL. PHP-Nuke comes with absolutely no warranty, for details, see the license.
Page Generation: 0.20 Seconds